Consor IP Consulting

applies AI-assisted methods to patent valuation, treating patents as strategic business assets in a data-driven valuation practice.

Country
United States
US
Coverage
CNEUINUS
regulatory-legal
Technologies
NameClusterRisk
Biotech IP valuationregulatory-legalLow

Compiled by BIOECON via the bioecon-brief pipeline.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.